Effect of divalproex on brain morphometry, chemistry, and function in youth at high-risk for bipolar disorder: A pilot study

Journal of Child and Adolescent Psychopharmacology

Volumn 19, Issue 1, 2009, Pages 51-59

  Chang, Kiki ^a   Karchemskiy, Asya ^a   Kelley, Ryan ^a   Howe, Meghan ^a   Garrett, Amy ^a   Adleman, Nancy ^a   Reiss, Allan ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VALPROATE SEMISODIUM;

ADOLESCENT; AMYGDALOID NUCLEUS; ARTICLE; BIPOLAR DISORDER; BRAIN CORTEX; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HAMILTON SCALE; HIGH RISK PATIENT; HUMAN; MALE; MONOTHERAPY; MOOD DISORDER; MOOD DYSREGULATION; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PILOT STUDY; PREFRONTAL CORTEX; PROGENY; THERAPY EFFECT; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; AMYGDALA; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRAIN; BRAIN CHEMISTRY; CHILD OF IMPAIRED PARENTS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MOOD DISORDERS; PILOT PROJECTS; PREFRONTAL CORTEX; RISK FACTORS; VALPROIC ACID;

EID: 60749126923     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2008.060     Document Type: Article

References (46)

1. th edition (DSM-IV). Washington (DC): American Psychiatric Association, 1994.
2. Bell EC, Willson MC, Wilman AH, Dave S, Silverstone PH: Differential effects of chronic lithium and valproate on brain activation in healthy volunteers. Hum Psychopharmacol 20:415-24, 2005.
3. Benes FM, Berretta S: GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25:1-2, 2001.
4. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, et al.: Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group [published erratum appears in JAMA271:1830, 1994] [see comments]. JAMA 271:918-2, 1994.
5. Brett M, Johnsrude IS, Owen AM: The problem of functional localization in the human brain. Nat Rev Neurosci 3:243-24, 2002.
6. Callahan PM, Paris JM, Cunningham KA, Shinnick-Gallagher P: Decrease of GABA-immunoreactive neurons in the amygdala after electrical kindling in the rat. Brain Res 555:335-339, 1991.
7. Cecil KM, DelBello MP, Sellars MC, Strakowski SM: Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders. J Child Adolesc Psychopharmacol 13:545-555, 2003.
8. Chang K, Steiner H, Dienes K, Adleman N, Ketter T: Bipolar offspring: A window into bipolar disorder evolution. Biol Psychiatry 53:945-951, 2003a.
9. Chang K, Adleman NE, Dienes K, Simeonova DI, Menon V, Reiss A: Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: A functional magnetic resonance imaging investigation. Arch Gen Psychiatry 61:781-792, 2004.
10. Chang K, Karchemskiy A, Barnea-Goraly N, Garrett A, Simeonova DI, Reiss A: Reduced amygdalar gray matter volume in familial pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:565-573, 2005.
11. Chang K, Howe M, Gallelli K, Miklowitz D: Prevention of pediatric bipolar disorder: Integration of neurobiological and psychosocial processes. Ann NY Acad Sci 1094:235-247, 2006.
12. Chang KD, Dienes K, Blasey C, Adleman N, Ketter T, Steiner H: Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms. J Clin Psychiatry 64:936-942, 2003b.
13. Chang KD, Wagner C, Garrett A, Howe M, Reiss A: A preliminary functional magnetic resonance imaging study of prefrontal-amygdalar activation changes in adolescents with bipolar depression treated with lamotrigine. Bipolar Disord 10:426-431, 2008.
14. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, Manji HK: The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 72:879-882, 1999.
15. DelBello MP, Zimmerman ME, Mills NP, Getz GE, Strakowski SM: Magnetic resonance imaging analysis of amygdala and other subcortical brain regions in adolescents with bipolar disorder. Bipolar Disord 6:43-52, 2004.
16. DelBello MP, Cecil KM, Adler CM, Daniels JP, Strakowski SM: Neurochemical effects of olanzapine in first-hospitalization manic adolescents: A proton magnetic resonance spectroscopy study. Neuropsychopharmacology 31:1264-1273, 2006.
17. Findling RL, Frazier TW, Youngstrom EA, McNamara NK, Stansbrey RJ, Gracious BL, Reed MD, Demeter CA, Calabrese JR: Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder. J Clin Psychiatry 68:781-88, 2007.
18. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, version 2.0) New York, NY: Biometric Research, New York State Psychiatric Institute, 1995.
19. Friedman SD, Dager SR, Parow A, Hirashima F, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol Psychiatry 56:340-348, 2004.
20. Gallelli KA, Wagner CM, Karchemskiy A, Howe M, Spielman D, Reiss A, Chang KD: N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder. Bipolar Disord 7:589-597, 2005.
21. Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL, DelBello MP, Soutullo C: Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. J Am Acad Child Adolesc Psychiatry 40:450-455, 2001.
22. Geller BG, Williams M, Zimerman B, Frazier J: WASH-U-KSADS (Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia) St. Louis (Missouri): Washington University, 1996.
23. Hashimoto R, Senatorov V, Kanai H, Leeds P, Chuang DM: Lithium stimulates progenitor proliferation in cultured brain neurons. Neuroscience 117:55-61, 2003.
24. Kates WR, Warsofsky IS, Patwardhan A, Abrams MT, Liu AM, Naidu S, Kaufmann WE, Reiss AL: Automated Talairach atlas-based parcellation and measurement of cerebral lobes in children. Psychiatry Res 91:11-30, 1999.
25. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997.
26. Kim D, Adalsteinsson E, Glover G, Spielman S: SVD regularization algorithm for improved high-order shimming. In: Proceedings of the 8th Annual Meeting of ISMRM Denver, p 1685, 2000.
27. Kowatch RA, Suppes T, Carmody TJ, Bucci JP, Hume JH, Kromelis M, Emslie GJ, Weinberg WA, Rush AJ: Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 39:713-720, 2000.
28. Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M: Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:213-23, 2005.
29. Ladouceur CD, Almeida JR, Birmaher B, Axelson DA, Nau S, Kalas C, Monk K, Kupfer DJ, Phillips ML: Subcortical gray matter volume abnormalities in healthy bipolar offspring: Potential neuroanatomical risk marker for bipolar disorder? J Am Acad Child Adolesc Psychiatry 47:532-539, 2008.
30. Laeng P, Pitts RL, Lemire AL, Drabik CE, Weiner A, Tang H, Thyagarajan R, Mallon BS, Altar CA: The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem 91:238-251, 2004.
31. Lang PJ, Bradley MM, Cuthbert BN: International Affective Picture System (IAPS): Technical manual and affective ratings. Gainesville (Florida): NIMH Center for the Study of Emotion and Attention, 1997.
32. Lapalme M, Hodgins S, LaRoche C: Children of parents with bipolar disorder: A metaanalysis of risk for mental disorders. Can J Psychiatry 42:623-63, 1997.
33. Lehmann H, Ebert U, Loscher W: Amygdala-kindling induces a lasting reduction of GABA-immunoreactive neurons in a discrete area of the ipsilateral piriform cortex. Synapse 29:299-309, 1998.
34. Loscher, W: Basic pharmacology of valproate: A review after 35 years of use for the treatment of epilepsy. CNS Drugs 16:669-694, 2002.
35. Manji HK, Lenox RH: Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: Molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 46:1328-1351, 1999.
36. Manji HK, Moore GJ, Chen G: Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: Implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry 48:740-754, 2000.
37. Moore CM: Brain-to-serum lithium ratio and age: An in vivo lithium magnetic resonance spectroscopy study. In: 57th Annual Convention of the Society for Biological Psychiatry Philadelphia, PA, p 4, 2002.
38. Patel NC, Delbello MP, Cecil KM, Stanford KE, Adler CM, Strakowski SM: Temporal change in N-acetyl-aspartate concentrations in adolescents with bipolar depression treated with lithium. J Child Adolesc Psychopharmacol 18:132-139, 2008.
39. Rainnie DG, Asprodini EK, Shinnick-Gallagher P: Inhibitory transmission in the basolateral amygdala. J Neurophysiol 66:999-1009, 1991.
40. Reiss AL, Hennessey JG, Rubin M, Beach L, Abrams MT, Warsofsky IS, Liu AM, Links JM: Reliability and validity of an algorithm for fuzzy tissue segmentation of MRI. J Comput Assist Tomogr 22:471-479, 1998.
41. Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC: Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Int Clin Psychopharmacol 18:73-79, 2003.
42. Singh MK, Delbello MP, Adler CM, Stanford KE, Strakowski SM: Neuroanatomical characterization of child offspring of bipolar parents. J Am Acad Child Adolesc Psychiatry 47:526-53, 2008.
43. Strakowski SM, Delbello MP, Adler CM: The functional neuroanatomy of bipolar disorder: A review of neuroimaging findings. Mol Psychiatry 10:105-116, 2005.
44. Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging. New York: Thieme Medical Publishers, Inc., 1988.
45. Wagner KD, Weller EB, Carlson GA, Sachs G, Biederman J, Frazier JA, Wozniak P, Tracy K, Weller RA, Bowden C: An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 41:1224-1230, 2002.
46. Wagner KD, Redden L, Kowatch R, Wilens TE, Segal S, Chang KD, Wozniak P, Vigna NV, Abi-Saab W, M. S: A double-blind, randomized, placebo-controlled trial of divalproex ER in the treatment of bipolar disorder in children and adolescents. (in press, 2009).